Holmusk, a data science and digital health company building a Real-World Evidence (RWE) platform for behavioral health, acquired Otsuka Health Solutions (OHS), a UK-based predictive mental health analytics provider.
The financial terms of the deal were not disclosed.
According to Holmusk’s statement, the acquisition of Otsuka Health Solutions deepens Holmusk’s footprint in the UK. It also paves the way for Holmusk to expand its partnerships with health systems working to transform behavioral healthcare.
With the acquisition, Holmusk adds OHS’s product, Management and Supervision Tool (MaST), to its suite of digital and analytic solutions to improve behavioral health outcomes. The MaST is a digital platform for care teams, leverages predictive analytics to identify people at greater risk of using crisis services and those who may require different services to support their recovery.
“This acquisition is an important milestone in our ambition to lead behavioral health innovation globally,” said Nawal Roy, Holmusk Founder, and CEO. “The UK has long held a reputation as a center of excellence for mental health research, and we are excited to bolster our presence here, leveraging OHS’s current role as a key partner with NHS Trusts, mental health research institutions, and providers.”
Caroline Gadd, now Director of Healthcare Solutions, Holmusk and 2020 NHS Innovation Accelerator Fellow said: “Holmusk’s capabilities and experience in measuring patient-reported outcomes will accelerate MaST’s development, allowing us to strive towards continually improving mental health outcomes as new models of care emerge across the NHS.”
Sixty-three digital health companies were acquired in Q1 2021, compared to 52 M&A transactions in Q4 2020. Recently, Olive, an AI-enabled workflow automation software for hospitals, acquired Empiric Health, an AI-powered clinical analytics platform designed to reduce clinical variation. The financial terms of the deal were not disclosed.